Verona Pharma PLC
NASDAQ:VRNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Verona Pharma PLC
NASDAQ:VRNA
|
UK |
|
Brown & Brown Inc
NYSE:BRO
|
US |
|
Quadrant Televentures Ltd
BSE:511116
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRNA's stock price target?
Not Available
VRNA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Verona Pharma PLC?
Projected CAGR
202%
The compound annual growth rate for Revenue over the next 3 years is 202%.